Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
Authors
Keywords
-
Journal
Cancers
Volume 7, Issue 3, Pages 1785-1805
Publisher
MDPI AG
Online
2015-09-03
DOI
10.3390/cancers7030861
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model
- (2015) Franziska Brandes et al. BMC CANCER
- The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell–endothelial cell interactions: antiangiogenic implications in pancreatic cancer
- (2014) Mishaal B. Patel et al. CARCINOGENESIS
- Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor
- (2014) Jun Oyanagi et al. EXPERIMENTAL CELL RESEARCH
- c-Met signaling in the development of tumorigenesis and chemoresistance: Potential applications in pancreatic cancer
- (2014) Daniel Delitto WORLD JOURNAL OF GASTROENTEROLOGY
- Intestinal GUCY2C Prevents TGF- Secretion Coordinating Desmoplasia and Hyperproliferation in Colorectal Cancer
- (2013) A. V. Gibbons et al. CANCER RESEARCH
- Hypoxia Triggers Hedgehog-Mediated Tumor-Stromal Interactions in Pancreatic Cancer
- (2013) T. R. Spivak-Kroizman et al. CANCER RESEARCH
- HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics
- (2013) Shinya Mizuno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
- (2013) Manish A. Shah et al. PLoS One
- Hepatocyte Growth Factor Signaling in Intrapancreatic Ductal Cells Drives Pancreatic Morphogenesis
- (2013) Ryan M. Anderson et al. PLoS Genetics
- Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors
- (2012) Andrew J. Wagner et al. CANCER
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone
- (2012) C. J. Ryan et al. CLINICAL CANCER RESEARCH
- Rationale and Design of MARQUEE: A Phase III, Randomized, Double-Blind Study of Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Patients With Locally Advanced or Metastatic, Nonsquamous, Non–Small-Cell Lung Cancer
- (2012) Giorgio V. Scagliotti et al. Clinical Lung Cancer
- Current concepts and novel targets in advanced pancreatic cancer
- (2012) Patrick Michl et al. GUT
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells
- (2012) ATSUSHI MATSUMURA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma
- (2012) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Inflammatory protein profiling of pancreatic cyst fluid using EUS-FNA in tandem with cytokine microarray differentiates between branch duct IPMN and inflammatory cysts
- (2012) Linda S. Lee et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
- (2012) Armando Santoro et al. LANCET ONCOLOGY
- Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
- (2011) Lucia De Monte et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Proteomic Analysis Reveals Warburg Effect and Anomalous Metabolism of Glutamine in Pancreatic Cancer Cells
- (2011) Weidong Zhou et al. JOURNAL OF PROTEOME RESEARCH
- A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
- (2011) P. Y. Wen et al. NEURO-ONCOLOGY
- Hepatocyte Growth Factor Inhibits Anoikis of Pancreatic Carcinoma Cells Through Phosphatidylinositol 3-Kinase Pathway
- (2011) Satoshi Watanabe et al. PANCREAS
- In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs
- (2011) Neelesh Sharma et al. Therapeutic Advances in Medical Oncology
- Evolution of Tumor Metabolism might Reflect Carcinogenesis as a Reverse Evolution process (Dismantling of Multicellularity)
- (2011) Khalid O. Alfarouk et al. Cancers
- Pancreatic Cancer: Pathobiology, Treatment Options, and Drug Delivery
- (2010) Jing Li et al. AAPS Journal
- Stromal biology and therapy in pancreatic cancer
- (2010) A. Neesse et al. GUT
- Hepatocyte growth factor and keratinocyte growth factor enhance IL-1-induced IL-8 secretion through different mechanisms in Caco-2 epithelial cells
- (2010) Benjamin L. Unger et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- HGF-induced invasion by prostate tumor cells requires anterograde lysosome trafficking and activity of Na+-H+ exchangers
- (2010) J. J. Steffan et al. JOURNAL OF CELL SCIENCE
- Mechanism of TNF-α-induced migration and hepatocyte growth factor production in human mesenchymal stem cells
- (2010) Aibin Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cancer cell-derived IL-1α promotes HGF secretion by stromal cells and enhances metastatic potential in pancreatic cancer cells
- (2010) Donghui Xu et al. JOURNAL OF SURGICAL ONCOLOGY
- The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine
- (2010) Toshikazu NAKAMURA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells
- (2009) Takeshi Kubota et al. CLINICAL & EXPERIMENTAL METASTASIS
- The Hormone Receptor GUCY2C Suppresses Intestinal Tumor Formation by Inhibiting AKT Signaling
- (2009) Jieru Egeria Lin et al. GASTROENTEROLOGY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer
- (2008) Yoshihiko Kitajima et al. CANCER SCIENCE
- Acid treatment of melanoma cells selects for invasive phenotypes
- (2008) Raymond E. Moellering et al. CLINICAL & EXPERIMENTAL METASTASIS
- Targeting the c-MET signaling pathway for cancer therapy
- (2008) Xiangdong Liu et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now